Pakistan has launched the Phase 3 clinical trial for the Chinese COVID-19 vaccine, announces Minister of Planning and Development Asad Umar announced on Tuesday.
The announcement was made after The National Command and Operation Centre (NCOC) meeting held earlier in the day.
According to NCOC, Trials for phases 1 and 2 for the vaccine were held in China. Pakistan, under a public-private partnership between the National Institute of Health (NIH) and CanSino, is among the countries which will carry out phase 3,
Sharing the update in a tweet today, the minister said that phase three trials for the vaccine developed by a Chinese company, China’s CanSino Biologics has been launched.
He further said a total of 40,000 people will participate in this trial in 7 countries.
Read More : COVID-19 vaccine’s clinical trials to begin in Pakistan this week
Out of these 40,000 people, 8000 to 10000 will be Pakistanis, Umar said. “Initial results expected in 4 to 6 months,” he added.
While addressing a presser alongside NIH Executive Director Maj Gen Aamer Ikram on Tuesday, Special Assistant to the Prime Minister on Health Dr. Faisal Sultan termed the trial an “important step” in which Pakistanis would also take part.
New Zealand took a 2-1 lead in the five-match series after beating Pakistan by four…
Congratulations are in order for actress Madiha Rizvi for tying the knot. Madiha Rizvi announced…
Bismah Maroof on Thursday announced retirement from international cricket;The former Women captain announced her decision…
Pakistan has rejected the recently released US human rights report terming it ‘biased and politicised’.…
Nobel laureate Malala Yousafzai Thursday clarified her "support for Gaza" amid backlash for her collaboration…
The ICC T20 World Cup trophy arrived in Pakistan on Thursday as part of its…